Spinal Muscular Atrophy Market Report

China Spinal Muscular Atrophy Industry Market Research Report 2023-2029

  • POSTDATE：Sep 15, 2023
  • PAGES：177
  • REPORT CODE：GMM1799531
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Spinal Muscular Atrophy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Astellas

    • Biogen Idec

    • Scholar Rock

    • Novartis AG

    • Cytokinetics, Inc

    By Type:

    • Gene Therapy

    • Non-gene therapy

    By Application:

    • Ambulatory Surgical Centers

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Spinal Muscular Atrophy Market Overview 2018-2029

    • 1.1 China Spinal Muscular Atrophy Industry Development Overview

    • 1.2 China Spinal Muscular Atrophy Industry Development History

    • 1.3 China Spinal Muscular Atrophy Industry Market Size (2018-2029)

    • 1.4 China Spinal Muscular Atrophy Market Analysis by Type from Production Side

      • 1.4.1 China Spinal Muscular Atrophy Production Volume, Production Value and Growth Rate of Gene Therapy (2018-2029)

      • 1.4.2 China Spinal Muscular Atrophy Production Volume, Production Value and Growth Rate of Non-gene therapy (2018-2029)

    • 1.5 China Spinal Muscular Atrophy Market Analysis by Application from Consumption End

      • 1.5.1 China Spinal Muscular Atrophy Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

      • 1.5.2 China Spinal Muscular Atrophy Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China Spinal Muscular Atrophy Market Analysis by Region

      • 1.6.1 North China Spinal Muscular Atrophy Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Spinal Muscular Atrophy Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Spinal Muscular Atrophy Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Spinal Muscular Atrophy Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Spinal Muscular Atrophy Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Spinal Muscular Atrophy Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Spinal Muscular Atrophy Market Size and Growth Rate from 2018-2029

    Chapter 2 China Spinal Muscular Atrophy Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Spinal Muscular Atrophy Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Spinal Muscular Atrophy Market Status and Competition Analysis in 2023

      • 2.2.3 China Spinal Muscular Atrophy Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Spinal Muscular Atrophy Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Spinal Muscular Atrophy Industry Development

    Chapter 3 Spinal Muscular AtrophyIndustry Chain Analysis

    • 3.1 Spinal Muscular Atrophy Industry Chain

    • 3.2 Spinal Muscular Atrophy Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Spinal Muscular Atrophy Market

    • 3.3 Spinal Muscular Atrophy Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Spinal Muscular Atrophy Market

    Chapter 4 China Spinal Muscular Atrophy Market, by Type

    • 4.1 China Spinal Muscular Atrophy Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Spinal Muscular Atrophy Total Production Volume and Growth Rate from Production Side

    • 4.5 China Spinal Muscular Atrophy Production Volume and Growth Rate, by Type

      • 4.5.1 China Spinal Muscular Atrophy Production Volume and Growth Rate of Gene Therapy

      • 4.5.2 China Spinal Muscular Atrophy Production Volume and Growth Rate of Non-gene therapy

    Chapter 5 China Spinal Muscular Atrophy Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Spinal Muscular Atrophy Total Market Size and Growth Rate from Consumption End

    • 5.5 China Spinal Muscular Atrophy Market Size and Growth Rate, by Application

      • 5.5.1 China Spinal Muscular Atrophy Market Size and Growth Rate of Ambulatory Surgical Centers

      • 5.5.2 China Spinal Muscular Atrophy Market Size and Growth Rate of Hospitals

    Chapter 6 China Spinal Muscular Atrophy Market, by Region

    • 6.1 China Spinal Muscular Atrophy Production Volume and Production Value, by Region

    • 6.2 China Spinal Muscular Atrophy Sales Volume and Sales Value, by Region

    Chapter 7 North China Spinal Muscular Atrophy Market Analysis

    • 7.1 North China Spinal Muscular Atrophy Market, by Type

    • 7.2 North China Spinal Muscular Atrophy Market, by Application

    Chapter 8 Central China Spinal Muscular Atrophy Market Analysis

    • 8.1 Central China Spinal Muscular Atrophy Market, by Type

    • 8.2 Central China Spinal Muscular Atrophy Market, by Application

    Chapter 9 South China Spinal Muscular Atrophy Market Analysis

    • 9.1 South China Spinal Muscular Atrophy Market, by Type

    • 9.2 South China Spinal Muscular Atrophy Market, by Application

    Chapter 10 East China Spinal Muscular Atrophy Market Analysis

    • 10.1 East China Spinal Muscular Atrophy Market, by Type

    • 10.2 East China Spinal Muscular Atrophy Market, by Application

    Chapter 11 Northeast China Spinal Muscular Atrophy Market Analysis

    • 11.1 Northeast China Spinal Muscular Atrophy Market, by Type

    • 11.2 Northeast China Spinal Muscular Atrophy Market, by Application

    Chapter 12 Southwest China Spinal Muscular Atrophy Market Analysis

    • 12.1 Southwest China Spinal Muscular Atrophy Market, by Type

    • 12.2 Southwest China Spinal Muscular Atrophy Market, by Application

    Chapter 13 Northwest China Spinal Muscular Atrophy Market Analysis

    • 13.1 Northwest China Spinal Muscular Atrophy Market, by Type

    • 13.2 Northwest China Spinal Muscular Atrophy Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Astellas

        • 14.1.1 Astellas Company Profile

        • 14.1.2 Astellas Spinal Muscular Atrophy Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Biogen Idec

        • 14.2.1 Biogen Idec Company Profile

        • 14.2.2 Biogen Idec Spinal Muscular Atrophy Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Scholar Rock

        • 14.3.1 Scholar Rock Company Profile

        • 14.3.2 Scholar Rock Spinal Muscular Atrophy Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Novartis AG

        • 14.4.1 Novartis AG Company Profile

        • 14.4.2 Novartis AG Spinal Muscular Atrophy Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Cytokinetics, Inc

        • 14.5.1 Cytokinetics, Inc Company Profile

        • 14.5.2 Cytokinetics, Inc Spinal Muscular Atrophy Market Performance

        • 14.5.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Spinal Muscular Atrophy Industry Research Conclusions

    • 15.2 Spinal Muscular Atrophy Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Spinal Muscular Atrophy Industry Market Size (2018-2029)

    • Figure China Spinal Muscular Atrophy Production Volume, Production Value and Growth Rate of Gene Therapy (2018-2029)

    • Figure China Spinal Muscular Atrophy Production Volume, Production Value and Growth Rate of Non-gene therapy (2018-2029)

    • Figure China Spinal Muscular Atrophy Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

    • Figure China Spinal Muscular Atrophy Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China Spinal Muscular Atrophy Market Size and Growth Rate from 2018-2029

    • Figure Central China Spinal Muscular Atrophy Market Size and Growth Rate from 2018-2029

    • Figure South China Spinal Muscular Atrophy Market Size and Growth Rate from 2018-2029

    • Figure East China Spinal Muscular Atrophy Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Spinal Muscular Atrophy Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Spinal Muscular Atrophy Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Spinal Muscular Atrophy Market Size and Growth Rate from 2018-2029

    • Figure Spinal Muscular Atrophy Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Spinal Muscular Atrophy Market Share by Type in 2018

    • Figure China Spinal Muscular Atrophy Market Share by Type in 2023

    • Figure China Spinal Muscular Atrophy Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Spinal Muscular Atrophy Production Volume and Growth Rate of Gene Therapy (2018-2023)

    • Figure China Spinal Muscular Atrophy Production Volume and Growth Rate of Non-gene therapy (2018-2023)

    • Figure China Spinal Muscular Atrophy Market Share by Application in 2018

    • Figure China Spinal Muscular Atrophy Market Share by Application in 2023

    • Figure China Spinal Muscular Atrophy Total Market Size and Growth Rate from Consumption End

    • Figure China Spinal Muscular Atrophy Market Size and Growth Rate of Ambulatory Surgical Centers (2018-2023)

    • Figure China Spinal Muscular Atrophy Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China Spinal Muscular Atrophy Production Volume by Region (2018-2023)

    • Table China Spinal Muscular Atrophy Production Volume Share by Region (2018-2023)

    • Figure China Spinal Muscular Atrophy Production Volume Share by Region (2018-2023)

    • Table China Spinal Muscular Atrophy Production Value by Region (2018-2023)

    • Table China Spinal Muscular Atrophy Production Value Share by Region (2018-2023)

    • Figure China Spinal Muscular Atrophy Production Value Share by Region (2018-2023)

    • Table China Spinal Muscular Atrophy Sales Volume by Region (2018-2023)

    • Table China Spinal Muscular Atrophy Sales Volume Share by Region (2018-2023)

    • Figure China Spinal Muscular Atrophy Sales Volume Share by Region (2018-2023)

    • Table China Spinal Muscular Atrophy Sales Value by Region (2018-2023)

    • Table China Spinal Muscular Atrophy Sales Value Share by Region (2018-2023)

    • Figure China Spinal Muscular Atrophy Sales Value Share by Region (2018-2023)

    • Table North China Spinal Muscular Atrophy Production Volume by Type (2018-2023)

    • Table North China Spinal Muscular Atrophy Production Volume Share by Type (2018-2023)

    • Figure North China Spinal Muscular Atrophy Production Volume Share by Type (2018-2023)

    • Table North China Spinal Muscular Atrophy Sales Volume by Application (2018-2023)

    • Table North China Spinal Muscular Atrophy Sales Volume Share by Application (2018-2023)

    • Figure North China Spinal Muscular Atrophy Sales Volume Share by Application (2018-2023)

    • Table Central China Spinal Muscular Atrophy Production Volume by Type (2018-2023)

    • Table Central China Spinal Muscular Atrophy Production Volume Share by Type (2018-2023)

    • Figure Central China Spinal Muscular Atrophy Production Volume Share by Type (2018-2023)

    • Table Central China Spinal Muscular Atrophy Sales Volume by Application (2018-2023)

    • Table Central China Spinal Muscular Atrophy Sales Volume Share by Application (2018-2023)

    • Figure Central China Spinal Muscular Atrophy Sales Volume Share by Application (2018-2023)

    • Table South China Spinal Muscular Atrophy Production Volume by Type (2018-2023)

    • Table South China Spinal Muscular Atrophy Production Volume Share by Type (2018-2023)

    • Figure South China Spinal Muscular Atrophy Production Volume Share by Type (2018-2023)

    • Table South China Spinal Muscular Atrophy Sales Volume by Application (2018-2023)

    • Table South China Spinal Muscular Atrophy Sales Volume Share by Application (2018-2023)

    • Figure South China Spinal Muscular Atrophy Sales Volume Share by Application (2018-2023)

    • Table East China Spinal Muscular Atrophy Production Volume by Type (2018-2023)

    • Table East China Spinal Muscular Atrophy Production Volume Share by Type (2018-2023)

    • Figure East China Spinal Muscular Atrophy Production Volume Share by Type (2018-2023)

    • Table East China Spinal Muscular Atrophy Sales Volume by Application (2018-2023)

    • Table East China Spinal Muscular Atrophy Sales Volume Share by Application (2018-2023)

    • Figure East China Spinal Muscular Atrophy Sales Volume Share by Application (2018-2023)

    • Table Northeast China Spinal Muscular Atrophy Production Volume by Type (2018-2023)

    • Table Northeast China Spinal Muscular Atrophy Production Volume Share by Type (2018-2023)

    • Figure Northeast China Spinal Muscular Atrophy Production Volume Share by Type (2018-2023)

    • Table Northeast China Spinal Muscular Atrophy Sales Volume by Application (2018-2023)

    • Table Northeast China Spinal Muscular Atrophy Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Spinal Muscular Atrophy Sales Volume Share by Application (2018-2023)

    • Table Southwest China Spinal Muscular Atrophy Production Volume by Type (2018-2023)

    • Table Southwest China Spinal Muscular Atrophy Production Volume Share by Type (2018-2023)

    • Figure Southwest China Spinal Muscular Atrophy Production Volume Share by Type (2018-2023)

    • Table Southwest China Spinal Muscular Atrophy Sales Volume by Application (2018-2023)

    • Table Southwest China Spinal Muscular Atrophy Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Spinal Muscular Atrophy Sales Volume Share by Application (2018-2023)

    • Table Northwest China Spinal Muscular Atrophy Production Volume by Type (2018-2023)

    • Table Northwest China Spinal Muscular Atrophy Production Volume Share by Type (2018-2023)

    • Figure Northwest China Spinal Muscular Atrophy Production Volume Share by Type (2018-2023)

    • Table Northwest China Spinal Muscular Atrophy Sales Volume by Application (2018-2023)

    • Table Northwest China Spinal Muscular Atrophy Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Spinal Muscular Atrophy Sales Volume Share by Application (2018-2023)

    • Table Astellas Company Profile

    • Table Astellas Spinal Muscular Atrophy Revenue, Price and Gross (2018-2023)

    • Table Biogen Idec Company Profile

    • Table Biogen Idec Spinal Muscular Atrophy Revenue, Price and Gross (2018-2023)

    • Table Scholar Rock Company Profile

    • Table Scholar Rock Spinal Muscular Atrophy Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Spinal Muscular Atrophy Revenue, Price and Gross (2018-2023)

    • Table Cytokinetics, Inc Company Profile

    • Table Cytokinetics, Inc Spinal Muscular Atrophy Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US